What is CommonQuant (Common Quant)?

CommonQuant, also written Common Quant, is an AI-powered trading platform that turns plain-English market ideas into live, rules-based strategies. It selects relevant instruments, writes indicator-based entry and exit rules, monitors the conditions continuously, and alerts users when conditions are met.

How does CommonQuant generate trading strategies?

You write a natural-language prompt describing your market idea. CommonQuant selects validated instruments, chooses from 20 supported technical indicators, and writes concrete entry and exit rules. The strategy then runs live and sends alerts through the channels available on your plan when conditions trigger.

What markets and instruments does CommonQuant support?

CommonQuant supports several thousand US equities and ETFs listed on Nasdaq, NYSE, NYSE American, and Cboe, plus major crypto assets such as Bitcoin. It does not support FX or futures.

How do I receive trading signal alerts?

CommonQuant provides an in-app signal inbox on all plans. Paid plans add email and Telegram, plus metered monthly SMS and WhatsApp allowances. Channel availability and allowances vary by plan.

Is CommonQuant free to use?

Yes. CommonQuant has a free tier with 1,000 starter credits, 200 monthly refill credits, up to three signal subscriptions, and in-app alerts. Paid plans start at $9/month, and no credit card is required to start.

Does CommonQuant provide financial advice?

No. CommonQuant is a quantitative tool for alpha validation and does not constitute financial advice. Past performance does not guarantee future results. Users are responsible for their own trading decisions.

Can I copy public trading strategies?

Yes. Users can browse, preview, and copy public community and AI-generated strategies into their own accounts. They can also follow strategists and take part in Arena competitions.

CommonQuant.ai Research

AI-generated trading idea · LONG · LLY

Defensive growth shines as rate fears ease — ride Eli Lilly's GLP-1 dominance

The broader stock market is breathing a sigh of relief as cooling job numbers ease fears of aggressive rate hikes. This favorable environment for stocks is the perfect backdrop for high-flying growth stories like Eli Lilly, which just secured massive Medicare coverage for its weight-loss drugs.

Idea

Eli Lilly has a fundamental catalyst with Medicare inclusion for GLP-1 drugs, effectively guaranteeing a massive new revenue stream. The stock is hitting highs just as the weak jobs report takes the threat of rate hikes off the table. High-growth, defensive stocks like pharmaceutical companies thrive when rates are stable because their future earnings become more valuable. This creates a perfect environment to buy the momentum in LLY.

Key details

LLYD1#stocks#healthcare#defensive_growth

Community

Upvotes

893

Views

Copies

Cosigns

News sources

U.S. economy added 57,000 jobs in June, less than expected; unemployment rate at 4.2% — CNBC
Stocks Climb as Fed Rate Hike Fears Ease on a Weak Jobs Report — Yahoo Finance
Eli Lilly Hits Highs on GLP-1 Medicare Inclusion, Huge Results — Yahoo Finance

Defensive growth shines as rate fears ease — ride Eli Lilly's GLP-1 dominance

Idea

Key details

Community

News sources

Related ideas

Related